Central pharmacokinetics of levodopa: Lessons from imaging studies.
Identifieur interne : 000303 ( Main/Exploration ); précédent : 000302; suivant : 000304Central pharmacokinetics of levodopa: Lessons from imaging studies.
Auteurs : A Jon StoesslSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antiparkinson Agents, Levodopa.
- drug effects : Brain.
- radionuclide imaging : Brain.
- Humans, Positron-Emission Tomography.
Abstract
Functional imaging may be particularly helpful for the assessment of levodopa (l-dopa) response and long-term complications of therapy in Parkinson's disease. Radiotracer imaging allows the quantitative determination of regional changes in blood flow and glucose metabolism, as well as alterations in brain connectivity and network activation and changes in dopamine receptors, non-dopaminergic neurotransmitter systems, and to a lesser extent, signaling pathways downstream to dopamine receptors. The focus of the present article, however, is the application of positron emission tomography (PET) to study the central pharmacokinetics of l-dopa. Radioligands with limited affinity for the dopamine D2 receptor are sensitive to changes in the levels of synaptic dopamine and can accordingly provide helpful insights into the magnitude and time course of dopamine release after l-dopa. Prolonged fluorodopa PET scans can be used to estimate the rate of dopamine turnover. Studies performed with these techniques have demonstrated increased dopamine turnover and increased but shorter duration release of dopamine after l-dopa as Parkinson's disease (PD) progresses, increased release of dopamine in patients with l-dopa-induced dyskinesia, and that aberrant patterns of dopamine release may actually predict the future development of motor fluctuations. Taken together, the studies provide in vivo validation for the hypothesis that pulsatile stimulation of dopamine receptors plays a critical role in the emergence of long-term motor complications of therapy. Similar approaches can be used to study the non-motor complications of PD and its treatment. Society.
DOI: 10.1002/mds.26046
PubMed: 25274160
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000373
- to stream PubMed, to step Curation: 000373
- to stream PubMed, to step Checkpoint: 000304
- to stream Ncbi, to step Merge: 004130
- to stream Ncbi, to step Curation: 004130
- to stream Ncbi, to step Checkpoint: 004130
- to stream Main, to step Merge: 000303
- to stream Main, to step Curation: 000303
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Central pharmacokinetics of levodopa: Lessons from imaging studies.</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name><affiliation><nlm:affiliation>Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, 2221 Wesbrook Mall, Vancouver, BC CANADA V6T 2B5.</nlm:affiliation><wicri:noCountry code="subField">BC CANADA V6T 2B5</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25274160</idno><idno type="pmid">25274160</idno><idno type="doi">10.1002/mds.26046</idno><idno type="wicri:Area/PubMed/Corpus">000373</idno><idno type="wicri:Area/PubMed/Curation">000373</idno><idno type="wicri:Area/PubMed/Checkpoint">000304</idno><idno type="wicri:Area/Ncbi/Merge">004130</idno><idno type="wicri:Area/Ncbi/Curation">004130</idno><idno type="wicri:Area/Ncbi/Checkpoint">004130</idno><idno type="wicri:Area/Main/Merge">000303</idno><idno type="wicri:Area/Main/Curation">000303</idno><idno type="wicri:Area/Main/Exploration">000303</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Central pharmacokinetics of levodopa: Lessons from imaging studies.</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name><affiliation><nlm:affiliation>Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, 2221 Wesbrook Mall, Vancouver, BC CANADA V6T 2B5.</nlm:affiliation><wicri:noCountry code="subField">BC CANADA V6T 2B5</wicri:noCountry></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (pharmacology)</term><term>Brain (drug effects)</term><term>Brain (radionuclide imaging)</term><term>Humans</term><term>Levodopa (pharmacology)</term><term>Positron-Emission Tomography</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Positron-Emission Tomography</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Functional imaging may be particularly helpful for the assessment of levodopa (l-dopa) response and long-term complications of therapy in Parkinson's disease. Radiotracer imaging allows the quantitative determination of regional changes in blood flow and glucose metabolism, as well as alterations in brain connectivity and network activation and changes in dopamine receptors, non-dopaminergic neurotransmitter systems, and to a lesser extent, signaling pathways downstream to dopamine receptors. The focus of the present article, however, is the application of positron emission tomography (PET) to study the central pharmacokinetics of l-dopa. Radioligands with limited affinity for the dopamine D2 receptor are sensitive to changes in the levels of synaptic dopamine and can accordingly provide helpful insights into the magnitude and time course of dopamine release after l-dopa. Prolonged fluorodopa PET scans can be used to estimate the rate of dopamine turnover. Studies performed with these techniques have demonstrated increased dopamine turnover and increased but shorter duration release of dopamine after l-dopa as Parkinson's disease (PD) progresses, increased release of dopamine in patients with l-dopa-induced dyskinesia, and that aberrant patterns of dopamine release may actually predict the future development of motor fluctuations. Taken together, the studies provide in vivo validation for the hypothesis that pulsatile stimulation of dopamine receptors plays a critical role in the emergence of long-term motor complications of therapy. Similar approaches can be used to study the non-motor complications of PD and its treatment. Society.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A Jon" last="Stoessl">A Jon Stoessl</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000303 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000303 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25274160
|texte= Central pharmacokinetics of levodopa: Lessons from imaging studies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25274160" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |